Detalles de la búsqueda
1.
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial.
Diabetes Obes Metab
; 25(1): 198-207, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089810
2.
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
Diabetes Obes Metab
; 24(8): 1578-1587, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35478433
3.
Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors.
Nephrology (Carlton)
; 26(5): 377-390, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33283420
4.
The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis.
Diabetes Obes Metab
; 22(4): 549-556, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31742881
5.
SGLT2 inhibitors' interaction with other renoactive drugs in type 2 diabetes patients: still a lot to learn.
Kidney Int
; 96(2): 283-286, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31331468
6.
Mineralocorticoid Antagonism and Diabetic Kidney Disease.
Curr Diab Rep
; 19(1): 4, 2019 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30673886
7.
Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?
Diabetes Obes Metab
; 21 Suppl 2: 24-33, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843294
8.
Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes.
Circulation
; 146(24): 1895-1897, 2022 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36508495
9.
Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes.
J Pers Med
; 13(5)2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240917
10.
The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet.
Kidney Int Rep
; 7(5): 1084-1092, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35570989
11.
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial.
Diabetes Care
; 44(2): 440-447, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318125
12.
Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors.
Kidney Int Rep
; 5(11): 2052-2054, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33163726
13.
Renal outcomes in CVOTs: keep calm and carry on.
Lancet Diabetes Endocrinol
; 6(9): 674-676, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29937268
Resultados
1 -
13
de 13
1
Próxima >
>>